Context switching.
Messages, meetings, twenty open tabs. It’s hard to do your best work when everything wants your attention.
Phase 1 // Early Waitlist Open
A performance nutraceutical capsule engineered for sustained attention under deadline pressure. Zero hidden fillers. Transparent clinical dosing.
Join Early Waitlist ↗Read Our Standards ↗LESS NOISE.
MORE YOU.
The work is waiting. Lock in.
THE IDEA
Messages, meetings, twenty open tabs. It’s hard to do your best work when everything wants your attention.
Quiet, decisive momentum. Put the phone face-down and give the task in front of you your attention.
Every active and exact milligram count published at launch. No proprietary blends. No mystery.
For the way you want to show up.
Our philosophy starts with these five things.
Make room for the task that matters.
Less noise. A clearer next step.
Show up for the difficult middle.
Find your rhythm. Keep your cool.
Build a ritual you can return to.
Phone face-down. Tabs closed. Pick the one thing that deserves your attention.
A small ritual to mark the start of your focus time. Your space, your pace.
The blank page. The next chapter. The idea that won’t leave you alone. Start there.
THE WORLD IS LOUD ENOUGH.
Fully disclosed doses. No proprietary blends. Formula details will be shared when finalised.
The first production batch will undergo independent testing. The report will be shared before sale.
LockIn is in development. Nothing is shipping yet. Join the waitlist for real progress, directly from us.
WHERE WE ARE
Last updated September 2026.
September 2026
Four actives + B-complex blend
In process
Being finalised
Comes with batch 1
Nothing is shipping yet
FOUNDERS DISPATCH
We live the same reality you do: long days, constant context switching, and work that deserves our full attention. We wanted a focus supplement built around clear evidence and honest disclosure.
Our commitment is simple: when we launch, every compound and milligram dose will be published, with human trial citations and independent batch reports. No proprietary blends. No shortcuts.
Meet the founders ↗Co-Founder · IIT Bombay
Co-Founder · Edtech and operations
NOOTROPICS, EXPLAINED
Nootropics are supplements people use to support focus, memory and mental clarity. LockIn is built around fully disclosed doses and third-party testing. It’s a supplement, not a substitute for sleep, food, movement or deliberate focus habits.
LockIn is a performance nutraceutical capsule engineered for cognitive focus and attention. It is formulated in a size 00 vegetarian (HPMC) capsule designed for Indian working professionals and students facing intense mental demands.
LockIn sits in the nootropic and focus supplement category: a capsule built to support attention and mental clarity during demanding work or study. We avoid hype, publish our dosing and lab reports at launch, and make no claims to treat or cure any condition.
Most focus supplements hide doses behind proprietary blends. LockIn commits to the opposite: every compound, every milligram and every third-party Certificate of Analysis is published in full, in a clean veg HPMC capsule.
If biohacking means using evidence-led tools to look after your focus, sleep and energy, then yes, LockIn is one of those tools. It is a supplement, not a substitute for sleep, food, movement or deliberate focus habits.
We are currently finalising the first 10,000-capsule pilot batch with our manufacturing partner. While we do not reveal the exact proprietary extraction ratios prior to launch, we have a standing commitment: at launch, every single compound, milligram dose, and third-party lab Certificate of Analysis will be published in full.
We do not promise artificial launch dates until quality testing is 100% verified. Joining the waitlist guarantees priority access and early-supporter pricing for the first 200 pilot allocations.
No. LockIn is categorized as a Nutraceutical under FSSAI regulations. It is not intended to treat, cure, or diagnose any medical or psychiatric condition.
YOUR NEXT CHAPTER STARTS HERE
No marketing spam. You will receive the formula disclosure, Certificate of Analysis, and early access link before general release.
Early access. Honest updates. No spam.